CIBC World Market’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.1M Buy
488,266
+120,984
+33% +$3.63M 0.02% 333
2025
Q4
$11.3M Buy
367,282
+87,350
+31% +$2.72M 0.02% 397
2025
Q3
$8.59M Buy
+279,932
New +$6.82M 0.02% 449
2020
Q4
Sell
-49,802
Closed -$1.82M 1285
2020
Q3
$1.82M Buy
49,802
+19,046
+62% +$689K 0.01% 512
2020
Q2
$1.04M Buy
+30,756
New +$838K ﹤0.01% 639

Other funds holding GMAB

CIBC World Market's GMAB Position: Q1 2026 in Review

CIBC World Market increased its Genmab (GMAB) stake by 33% in Q1 2026, buying an estimated $3.63M and bringing the position to 488,266 shares worth $13.1M. The position accounts for 0.02% of the portfolio, ranked #333.

CIBC World Market first reported a position in GMAB in Q2 2020 and has held it in 5 quarters since. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • CIBC World Market held 488,266 shares of Genmab worth $13.1M as of Q1 2026.
  • CIBC World Market bought 120,984 Genmab shares in Q1 2026, an estimated $3.63M.
  • Genmab made up 0.02% of CIBC World Market's portfolio in Q1 2026, its #333 holding.
  • CIBC World Market first reported a position in Genmab in Q2 2020 and has held it in 5 quarters since.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.